Product Information

LEVOTHYROXINE 300 MCG TABLET is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.0999 per EA under NDC 33342040444. Its NADAC has been published 125 times since Apr 3, 2024.

FDA first approved this application on Dec 21, 2022. Its Orange Book therapeutic-equivalence code is AB1,AB2,AB3,AB4 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LEVOTHYROXINE 300 MCG TABLET

LEVOTHYROXINE SODIUM
$0.0999per EA

Strength

300 ug/1

NDC

33342040444

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

LEVOTHYROXINE SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA211417

FDA Approved

12/21/2022

TE Code

AB1,AB2,AB3,AB4

On Market Since

12/21/2022

Pharmacological Classes

Thyroxine
l-Thyroxine

Price Statistics

The NADAC for LEVOTHYROXINE 300 MCG TABLET has been published 125 times since Apr 3, 2024, and over the history we have for it it has declined 41.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0999 per EA
All-time high$0.1708 (Apr 10, 2024)
All-time low$0.0715 (Jul 17, 2024)
52-week high$0.1278
52-week low$0.0999
Median price$0.1156
Average price$0.1153
Largest weekly change+78.9% (Aug 21, 2024)
Weeks tracked125
Tracking sinceApr 3, 2024

Price History

1W

-6.4%

1M

-7.9%

3M

-11.3%

6M

-13.6%

1Y

-21.9%

3Y

N/A

5Y

N/A

All

-41.5%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LEVOTHYROXINE 300 MCG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LEVOTHYROXINE 300 MCG TABLET, manufactured by Macleods Pharmaceuticals Limited, is $0.0999 per EA (NDC 33342040444), effective Aug 19, 2026.

How has the price of LEVOTHYROXINE 300 MCG TABLET changed over time?

Over the history we have for it, the NADAC for LEVOTHYROXINE 300 MCG TABLET has declined 41.5%. It has been tracked across 125 weekly CMS publications since Apr 3, 2024.

What are the highest and lowest recorded NADAC prices for LEVOTHYROXINE 300 MCG TABLET?

Since Apr 3, 2024, the NADAC for LEVOTHYROXINE 300 MCG TABLET has ranged from a low of $0.0715 (Jul 17, 2024) to a high of $0.1708 (Apr 10, 2024), with a median of $0.1156 per EA.

Are there cheaper alternatives to LEVOTHYROXINE 300 MCG TABLET?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LEVOTHYROXINE 300 MCG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LEVOTHYROXINE 300 MCG TABLET?

LEVOTHYROXINE 300 MCG TABLET (NDC 33342040444) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.